Skip to main content
. 2014 Jul;3(4):351–367. doi: 10.3978/j.issn.2225-319X.2014.07.05

Table 7. Thirty-day outcomes for patients treated with endovascular approach.

First author Year n Endovascular fenestration Aortic stenting Aortic stent-graft Iliac stent-ing Technical success 30-day clinical success 30-day morbidity 30-day redo Date of redo (time post-treatment) Type of redo 30-day mortality
Lookstein (16) 2001 1 1 0 0 0 0 0 1 GI and liver ischemia 1 36 hours Exploratory laparotomy 1
Lauterbach (17) 2001 2 2 (1 balloon + 1 balloon & iliac stenting) 0 0 0 NS 2 0 NS 0
Eggebrecht (20) 2003 1 1 (14 mm balloon) 0 0 1 1 0 ARF and transient HD for reperfusion syndrome 1 NS 1 thoracic aortic stent-graft to seal proximal entry tear 0
Vedantham (21) 2003 7 7 4 0 5 6 5 NS NS NS
Fleck (22) 2004 1 0 0 1 (2 talent stent-grafts) 0 1 0 Bowel ischemia and compartment syndrome of lower limb and ARF with temporary dialysis 1 1st and 2nd days 1 inferior mesenteric artery stenting for bowel ischemia; 1 left lower limb fasciotomy 0
Lorenzen (23) 2004 1 0 0 1 Talent stent-graft 0 1 0 ARF for rhabdo-myolysis and temporary hemodialysis 1 1st, 4th, 6th and
9th days fasciotomies
3 wound debridements and fasciotomies of right forearm; 1 right forearm amputation 0
Tan (24) 2004 1 1 (stenting) 0 0 0 1 1 0 0 0
Yamaghchi (25) 2006 1 1 (12 mm balloon) 0 0 0 1 1 0 1 14th day Adjunctive endovascular fenestration + wall stent deployment 0
Henke (26) (IRAD data)* 2006 8 NS NS NS NS NS NS NS NS NS NS NS
Henke (26) (local series)* 2006 24 18 13 0 12 NS NS NS NS NS NS NS
Verhoye (30) 2008 3 0 0 3 1 NS 2 NS NS 1
Fujita (31) 2009 1 0 1 (bare metal 10 mm × 57 mm) 0 0 1 1 0 0 0
Iyer (32) 2009 1 0 0 1 (valiant free-flo) 0 1 0 ARF 0 0
Vulev (35) 2011 1 0 0 1 (valiant) 0 1 1 0 0 0
Sfyroereas (36) 2011 10 0 3 10 3 NS 8 NS NS 0
Narita (38) 2012 1 0 0 0 1 1 0 Recurrent implanted stent collapse 1 4th and 9th days 1-adjunctive common iliac stenting. 2-endovascular aortic fenestration with stent deployment 0
Corfield (42) 2014 1 0 0 1 1 NS 1 0 0 0
Overall 65 31/57 (54%) 21/57 (37%) 18/57 (32%) 24/57 (42%) 15/17 (88%) 22/33 (67%) 6/13 (46%) 6/11 (55%) 2/26 (8%)

*, overlap of 18 patients. NS, not specified; n, number of patients; GI, gastrointestinal; ARF, acute renal failure; HD, hemodialysis.